共 153 条
[1]
Bartlett JG(2002)Antibiotic-associated diarrhoea N Engl J Med 346 334-339
[2]
McFarland LV(1998)Epidemiology, risk factors and treatment for antibiotic-associated diarrhoea Dig Dis 16 292-307
[3]
Viswanathan VK(2010)Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions Gut Microbes 1 234-242
[4]
Mallozzi MJ(2010)The emergence of “hypervirulence” in Clostridium difficile Int J Med Microbiol 300 387-395
[5]
Vedantam G(2007)The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences Infect Control Hosp Epidemiol 28 1219-1227
[6]
Cartman ST(2009)Review of current literature on the economic burden of Clostridium difficile infection Infect Control Hosp Epidemiol 30 57-66
[7]
Heap JT(2011)Clostridium difficile infection in Europe: a hospital-based survey Lancet 377 63-73
[8]
Kuehne SA(1989)Prevention of antibiotic-associated diarrhoea by Saccharomyces boulardii: a prospective study Gastroenterology 96 981-988
[9]
Cockayne A(2009)Does PPI therapy predispose to Clostridium difficile infection? Nat Rev Gastroenterol Hepatol 6 555-557
[10]
Minton NP(2006)Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy CMAJ 175 745-748